ISENTRESS (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the ISENTRESS drug offered from Merck Sharp & Dohme Corp.. This HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | RALTEGRAVIR |
| SUBSTANCE NAME: | RALTEGRAVIR POTASSIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-10-12 |
| END MARKETING DATE: | 0000-00-00 |
ISENTRESS HUMAN PRESCRIPTION DRUG Details:
| Item Description | ISENTRESS from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2007-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-0227_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec |
| PRODUCT NDC: | 0006-0227 |
| APPLICATION NUMBER: | NDA022145 |
Other RALTEGRAVIR POTASSIUM Pharmaceutical Manufacturers / Labelers:
